Natario Couser, MD, MS

Assistant professor

Department

Pediatrics

Research areas

Research and scholarly activities have been an integral component of Dr. Couser’s career path. Dr. Couser is one of only a few individuals in the country board certified in both ophthalmology and clinical genetics, and has been the principal investigator on eight clinical trial/IRB studies and a co-investigator on others. He has participated with nine national committees/advisory panels including serving on a writing committee for the American Academy of Ophthalmology, a member for the Patient-Centered Outcomes Research Institute (PCORI) Advisory Panel, a grant review panelist for the National Institutes of Health (NIH)/National Eye Institute (NEI) and serves as the Vice Chair for the Diversity Equity and Inclusion committee for the American College of Medial Genetics and Genomics. Dr. Couser has been credited with over 100 book chapter, journal article and abstract publications, and has presented numerous invited lectures. He has special research interests in visual problems in school-aged children, pediatric instrument-based vision screening in the preschool population, and genetic eye diseases including rare inherited disorders affecting the eyes. Recent IRB studies include:.

• Principal Investigator at VCU for Epidemiology of Strabismus and Cataracts in Saint Vincent and the Grenadines: An Analysis of a Pediatric Population from 2002-2020
• Participating with Clinical Trial ACNS1833, A Phase 3 Randomized Non-Inferiority Study of Carboplatin and Vincristine versus Selumetinib in Newly Diagnosed or Previously Untreated Low-Grade Glioma (LGG) not associated with BRAFV600E Mutations or Systemic Neurofibromatosis Type 1 (NF1)
• Principal Investigator at VCU for Characterizing the Timeframe from Initial Onset of Visual Symptoms to Date of the Diagnosis Confirmation of Patients with Inherited Retinopathies
• Principal Investigator at VCU for Diagnostic Yield of Genetic Testing of Patients Seen at VCU Ophthalmic Genetics Clinic
• Principal Investigator at VCU for A Retrospective Review of Ophthalmic Manifestations in COVID-19 Patients at Virginia Commonwealth University Health Systems
• Participating with Clinical Trial ACNS1831, A Phase 3 Randomized Study of Selumetinib versus Carboplatin/Vincristine in Newly Diagnosed or Previously Untreated Neurofibromatosis Type 1 (NF1) Associated Low-Grade Glioma (LGG)

View full list of publications

CHRI theme

Personalized and Translational Medicine

< BACK